I do think this is a good stock to accumulate but setting your hopes on cannepil to succeed in markets where epidiolex already exists is foolish. GW Pharma is a powerful company rumoured to be backed by Bayer and their patents are scary good. MGC needs to focus on the cannepil in markets where epidiolex is not.
I do think this is a good stock to accumulate but setting your...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.010(3.13%) |
Mkt cap ! $15.97M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 32.0¢ | $7.497K | 22.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 823 | 3 |
View Market Depth
| Last trade - 15.38pm 29/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |